Harvard Bioscience (HBIO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Harvard Bioscience Revenue Highlights

Latest Revenue (Y)

$86.55M

Latest Revenue (Q)

$22.73M

Main Segment (Y)

Instruments, Equipment, Software, and Accessories

Main Geography (Y)

UNITED STATES

Harvard Bioscience Revenue by Period

Harvard Bioscience Revenue by Year

Date	Revenue	Change
2025-12-31	$86.55M	-8.06%
2024-12-31	$94.14M	-16.14%
2023-12-31	$112.25M	-0.96%
2022-12-31	$113.33M	-4.68%
2021-12-31	$118.90M	16.46%
2020-12-31	$102.10M	-12.12%
2019-12-31	$116.18M	-3.81%
2018-12-31	$120.77M	18.54%
2017-12-31	$101.88M	-2.52%
2016-12-31	$104.52M	-3.81%
2015-12-31	$108.66M	0.00%
2014-12-31	$108.66M	3.32%
2013-12-31	$105.17M	-5.40%
2012-12-31	$111.17M	2.12%
2011-12-31	$108.86M	0.63%
2010-12-31	$108.18M	26.12%
2009-12-31	$85.77M	-2.59%
2008-12-31	$88.05M	5.57%
2007-12-31	$83.41M	9.49%
2006-12-31	$76.18M	12.98%
2005-12-31	$67.43M	-27.18%
2004-12-31	$92.60M	6.26%
2003-12-31	$87.14M	51.87%
2002-12-31	$57.38M	40.40%
2001-12-31	$40.87M	33.67%
2000-12-31	$30.57M	16.80%
1999-12-31	$26.18M	115.38%
1998-12-31	$12.15M	-

Harvard Bioscience generated $86.55M in revenue during NA 2025, up -8.06% compared to the previous quarter, and up 84.77% compared to the same period a year ago.

Harvard Bioscience Revenue by Quarter

Date	Revenue	Change
2026-06-30	$22.73M	9.50%
2026-03-31	$20.75M	-12.56%
2025-12-31	$23.73M	15.27%
2025-09-30	$20.59M	0.69%
2025-06-30	$20.45M	-6.08%
2025-03-31	$21.77M	-11.33%
2024-12-31	$24.56M	11.77%
2024-09-30	$21.97M	-4.88%
2024-06-30	$23.10M	-5.77%
2024-03-31	$24.51M	-12.93%
2023-12-31	$28.15M	11.00%
2023-09-30	$25.36M	-11.81%
2023-06-30	$28.76M	-4.06%
2023-03-31	$29.98M	5.45%
2022-12-31	$28.43M	5.59%
2022-09-30	$26.92M	-7.83%
2022-06-30	$29.21M	1.49%
2022-03-31	$28.78M	-12.94%
2021-12-31	$33.05M	11.44%
2021-09-30	$29.66M	1.60%
2021-06-30	$29.20M	8.18%
2021-03-31	$26.99M	-12.89%
2020-12-31	$30.98M	28.90%
2020-09-30	$24.04M	3.13%
2020-06-30	$23.31M	-1.95%
2020-03-31	$23.77M	-23.25%
2019-12-31	$30.97M	12.96%
2019-09-30	$27.42M	-7.32%
2019-06-30	$29.58M	4.90%
2019-03-31	$28.20M	-16.71%
2018-12-31	$33.86M	18.24%
2018-09-30	$28.64M	-9.16%
2018-06-30	$31.52M	17.80%
2018-03-31	$26.76M	-2.56%
2017-12-31	$27.46M	9.63%
2017-09-30	$25.05M	-0.65%
2017-06-30	$25.21M	4.38%
2017-03-31	$24.16M	-8.55%
2016-12-31	$26.41M	5.63%
2016-09-30	$25.01M	-4.32%
2016-06-30	$26.14M	-3.07%
2016-03-31	$26.96M	-4.96%
2015-12-31	$28.37M	10.26%
2015-09-30	$25.73M	-10.66%
2015-06-30	$28.80M	11.79%
2015-03-31	$25.76M	-15.15%
2014-12-31	$30.36M	19.32%
2014-09-30	$25.45M	-5.60%
2014-06-30	$26.96M	4.11%
2014-03-31	$25.89M	-7.04%
2013-12-31	$27.85M	10.81%
2013-09-30	$25.14M	-3.67%
2013-06-30	$26.09M	0.03%
2013-03-31	$26.09M	-7.66%
2012-12-31	$28.25M	8.22%
2012-09-30	$26.10M	-8.39%
2012-06-30	$28.50M	0.61%
2012-03-31	$28.32M	-2.43%
2011-12-31	$29.03M	10.03%
2011-09-30	$26.38M	-2.81%
2011-06-30	$27.14M	3.16%
2011-03-31	$26.31M	-10.87%
2010-12-31	$29.52M	11.60%
2010-09-30	$26.45M	2.12%
2010-06-30	$25.91M	-1.50%
2010-03-31	$26.30M	-4.89%
2009-12-31	$27.65M	31.69%
2009-09-30	$21.00M	16.34%
2009-06-30	$18.05M	-5.36%
2009-03-31	$19.07M	-17.27%
2008-12-31	$23.05M	15.32%
2008-09-30	$19.99M	-13.28%
2008-06-30	$23.05M	4.96%
2008-03-31	$21.96M	-10.48%
2007-12-31	$24.53M	-

Harvard Bioscience generated $22.73M in revenue during Q2 2026, up 9.50% compared to the previous quarter, and up 104.38% compared to the same period a year ago.

Harvard Bioscience Revenue Breakdown

Harvard Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Instruments, Equipment, Software, and Accessories	$78.26M	$86.96M	$105.72M	$108.17M	$114.11M
Service, Maintenance, and Warranty Contracts	$8.29M	$7.17M	$6.53M	$5.17M	$4.79M

Harvard Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 25: Instruments, Equipment, Software, and Accessories (90.42%), and Service, Maintenance, and Warranty Contracts (9.58%).

Quarterly Revenue by Product

Product/Service	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Instruments, Equipment, Software, and Accessories	$20.30M	$18.57M	$21.64M	$18.58M	$18.18M	$19.86M	$43.66M	$20.54M	$22.76M	$26.45M	$23.50M	$27.27M	$28.49M	$27.16M	$25.70M	$27.77M	$27.54M	$31.81M	$28.48M	$27.99M
Service, Maintenance, and Warranty Contracts	$2.42M	$2.19M	$2.10M	$2.01M	$2.27M	$1.91M	$3.99M	$1.43M	$1.75M	$1.70M	$1.86M	$1.49M	$1.48M	$1.27M	$1.22M	$1.44M	$1.24M	$1.24M	$1.18M	$1.21M

Harvard Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Instruments, Equipment, Software, and Accessories (89.34%), and Service, Maintenance, and Warranty Contracts (10.66%).

Harvard Bioscience Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
UNITED STATES	$38.97M	$41.74M	$48.20M	$49.91M	$49.83M
Americas, Other	$3.23M	$3.60M	-	-	-
Asia, Other	$6.68M	$7.10M	-	-	-
CHINA	$10.97M	$24.82M	-	-	-
EMEA	$26.71M	$28.41M	-	-	-
Greater China	-	$13.30M	$18.49M	$16.39M	-
Rest of the World	-	-	$12.76M	$16.34M	$8.49M
Europe	-	-	$32.80M	$30.69M	$35.77M

Harvard Bioscience's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (45.02%), EMEA (30.86%), CHINA (12.67%), Asia, Other (7.72%), and Americas, Other (3.73%).

Quarterly Revenue by Country

Country	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Asia, Other	$1.49M	$1.82M	$1.59M	$1.40M	$1.33M	$2.35M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
CHINA	$3.08M	$2.81M	$3.64M	$2.15M	$2.45M	$2.73M	$6.73M	$5.62M	$6.73M	-	-	-	-	-	-	-	-	-	-	-
Americas, Other	$878.00K	$847.00K	$791.00K	$1.19M	$422.00K	$829.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EMEA	$6.78M	$6.47M	$7.48M	$6.61M	$6.59M	$6.03M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$10.50M	$8.80M	$10.23M	$9.25M	$9.66M	$9.83M	$21.05M	$9.71M	$10.98M	$11.55M	$12.02M	$12.34M	$12.30M	$11.63M	$11.51M	$14.07M	$12.24M	$12.53M	$12.71M	$13.15M
Greater China	-	-	-	-	-	-	$6.18M	$2.73M	$4.38M	$10.86M	$3.49M	$4.14M	-	-	-	-	-	-	-	-
Rest of the World	-	-	-	-	-	-	-	$3.03M	$2.57M	$5.56M	$2.79M	$2.96M	$1.45M	$11.15M	$1.34M	$2.32M	$1.98M	$4.10M	$1.43M	$2.33M
Europe	-	-	-	-	-	-	-	$6.50M	$6.58M	$8.96M	$7.06M	$9.33M	$7.44M	$8.33M	$7.34M	$7.19M	$7.82M	$10.20M	$8.37M	$8.03M
HONG KONG	-	-	-	-	-	-	-	-	-	-	-	-	$3.51M	-	-	-	-	-	-	-
Rest of Asia	-	-	-	-	-	-	-	-	-	-	-	-	$5.27M	-	-	-	-	-	-	-
Asia	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$7.16M	$5.70M

Harvard Bioscience's latest quarterly revenue breakdown by geography, as of Jun 26: UNITED STATES (46.21%), EMEA (29.85%), CHINA (13.53%), Asia, Other (6.54%), and Americas, Other (3.86%).

Harvard Bioscience Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
HBIO	Harvard Bioscience	$86.55M	$22.73M
COSM	Cosmos Health	$65.27M	$18.99M
NXGL	NEXGEL	$11.42M	$2.65M
CLGN	CollPlant Bio	$10.96M	$98.00K
FEMY	Femasys	$2.29M	$331.83K
SONN	Sonnet BioTherapeutics	$1.00M	-
NXL	Nexalin	$301.65K	$12.16K
NCNA	NuCana	-	-
TAOX	TAO Synergies	-	-

HBIO Revenue FAQ

What is Harvard Bioscience’s yearly revenue?

Harvard Bioscience's yearly revenue for 2025 was $86.55M, representing a decrease of -8.06% compared to 2024. The company's yearly revenue for 2024 was $94.14M, representing a decrease of -16.14% compared to 2023. HBIO's yearly revenue for 2023 was $112.25M, representing a decrease of -0.96% compared to 2022.

What is Harvard Bioscience’s quarterly revenue?

Harvard Bioscience's quarterly revenue for Q2 2026 was $22.73M, a 9.50% increase from the previous quarter (Q1 2026), and a 11.13% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $20.76M, a -12.56% decrease from the previous quarter (Q4 2025), and a -4.68% decrease year-over-year (Q1 2025). HBIO's quarterly revenue for Q4 2025 was $23.74M, a 15.27% increase from the previous quarter (Q3 2025), and a -3.34% decrease year-over-year (Q4 2024).

What is Harvard Bioscience’s revenue growth rate?

Harvard Bioscience's revenue growth rate for the last 3 years (2023-2025) was -22.90%, and for the last 5 years (2021-2025) was -27.21%.

What are Harvard Bioscience’s revenue streams?

Harvard Bioscience's revenue streams in c 25 are Instruments, Equipment, Software, and Accessories, and Service, Maintenance, and Warranty Contracts. Instruments, Equipment, Software, and Accessories generated $78.26M in revenue, accounting 90.42% of the company's total revenue, down -10.01% year-over-year. Service, Maintenance, and Warranty Contracts generated $8.29M in revenue, accounting 9.58% of the company's total revenue, up 15.60% year-over-year.

What is Harvard Bioscience’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Harvard Bioscience was Instruments, Equipment, Software, and Accessories. This segment made a revenue of $78.26M, representing 90.42% of the company's total revenue.